GEE Group Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
GEE Group Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2012 to Q2 2024.
  • GEE Group Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was -$2.55M, a 62.3% increase year-over-year.
  • GEE Group Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was -$4.09M, a 32.9% increase year-over-year.
  • GEE Group Inc. annual Income Tax Expense (Benefit) for 2023 was -$7.25M, a 1333% decline from 2022.
  • GEE Group Inc. annual Income Tax Expense (Benefit) for 2022 was $588K, a 914% increase from 2021.
  • GEE Group Inc. annual Income Tax Expense (Benefit) for 2021 was $58K, a 90.3% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$4.09M -$2.55M +$4.21M +62.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$8.3M -$915K -$973K -1678% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$7.32M $0 -$73K -100% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-13
Q3 2023 -$7.25M -$628K -$1.16M -219% Jul 1, 2023 Sep 30, 2023 10-K 2023-12-18
Q2 2023 -$6.09M -$6.75M -$6.85M -7133% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $756K $58K +$66K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $690K $73K +$102K Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2022 $588K $529K +$164K +44.9% Jul 1, 2022 Sep 30, 2022 10-K 2023-12-18
Q2 2022 $424K $96K +$125K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $299K -$8K -$125K -107% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $424K -$29K +$366K +92.7% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q3 2021 $58K $365K -$141K -27.9% Jul 1, 2021 Sep 30, 2021 10-K 2022-12-20
Q2 2021 $199K -$29K +$61K +67.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $138K $117K +$107K +1070% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $31K -$395K -$566K -331% Oct 1, 2020 Dec 31, 2020 10-Q 2021-02-16
Q3 2020 $597K $506K +$537K Jul 1, 2020 Sep 30, 2020 10-K 2021-12-23
Q2 2020 $60K -$90K +$16K +15.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $44K $10K +$26K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $18K $171K -$352K -67.3% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-16
Q3 2019 $370K -$31K -$631K -105% Jul 1, 2019 Sep 30, 2019 10-K 2020-12-29
Q2 2019 $1M -$106K +$301K +74% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $700K -$16K -$710K -102% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $1.41M $523K +$551K Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-13
Q3 2018 $859K $600K +$6.95M Jul 1, 2018 Sep 30, 2018 10-K 2019-12-23
Q2 2018 -$6.09M -$407K -$609K -301% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$5.48M $694K +$630K +984% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$6.11M -$28K -$94K -142% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-14
Q3 2017 -$6.02M -$6.35M Jul 1, 2017 Sep 30, 2017 10-K 2018-12-27
Q2 2017 $202K +$201K +20100% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $64K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $66K Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-14
Q2 2016 $1K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q3 2014 $24K $24K +$24K Jul 1, 2014 Sep 30, 2014 10-K 2015-12-29
Q2 2014 $0 $0 $0 Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-14
Q1 2014 $0 $0 -$8K -100% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-20
Q4 2013 $8K $0 $0 Oct 1, 2013 Dec 31, 2013 10-Q 2014-02-19
Q3 2013 $8K $0 Jul 1, 2013 Sep 30, 2013 10-K 2014-12-22
Q2 2013 $0 $0 Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 $8K +$8K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-20
Q4 2012 $0 Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-19
Q2 2012 $0 Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-15
Q1 2012 $0 Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.